Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Toujeo® (insulin glargine) – Expanded indication
November 26, 2019 - The FDA approved Sanofi’s Toujeo (insulin glargine), to improve glycemic control in adults and pediatric patients 6 years and older with diabetes mellitus (DM).
